Nitric oxide and downstream second messenger cGMP and cAMP enhance adipogenesis in primary human preadipocytes.

BACKGROUND AIMS Obesity is correlated with chronic low-grade inflammation. Thus the induction of inflammation could be used to stimulate adipose tissue formation in tissue-engineering approaches. As nitric oxide (NO) is a key regulator of inflammation, we investigated the effect of NO and its downstream signaling molecule guanosine 3',5'-cyclic monophosphate (cGMP) as well as adenosine 3',5'-cyclic monophosphate (cAMP) on preadipocytes in vitro. METHODS Preadipocytes were isolated from human subcutaneous adipose tissue, cultured until confluence, and differentiated. The NO donor diethylenetriamine (DETA)/NO (30-150 microm) was added during proliferation and differentiation. Additionally, cGMP/cAMP analogs 8-bromoguanosine 3',5'-cyclic monophosphate (8-Br-cGMP), 8-(4-chlorophenylthio)-guanosine 3',5'-cyclic monophosphate (8-pCPT-cGMP) and 8-bromoadenosine 3',5'-cyclic monophosphate (8-Br-cAMP), and the adenylyl cyclase activator forskolin, specific guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-a]quinoxalin-1-one (ODQ) and adenylyl cyclase inhibitor 2'-5'-dideoxyadenosine (ddA), were applied. Proliferation and differentiation were evaluated. RESULTS DETA/NO in combination with the standard differentiation procedure significantly enhanced maturation of precursor cells to adipocytes. Proliferation, in contrast, was inhibited in the presence of NO. The application of cGMP and cAMP, respectively, increased pre-adipocyte differentiation to an even higher extent than NO. Inhibitors of the underlying pathways caused a significant decrease in adipogenic conversion. CONCLUSIONS Our results support the application of NO donors during transplantation of preadipocytes in a 3-dimensional setting to accelerate and optimize differentiation. The results suggest that, instead of the rather instable and reactive molecule NO, the application of cGMP and cAMP would be even more effective because these substances have a stronger adipogenic effect on preadipocytes and a longer half-life than NO. Also, by applying inhibitors of the underlying pathways, the induced inflammatory condition could be regulated to the desired level.

[1]  K. Akimoto,et al.  Stimulatory and Inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/Gi pathways in rat cultured adipocytes , 2009, Regulatory Peptides.

[2]  P. Blondeel,et al.  Human clinical experience with adipose precursor cells seeded on hyaluronic acid-based spongy scaffolds. , 2008, Biomaterials.

[3]  K. Kristiansen,et al.  Cyclic AMP (cAMP)-Mediated Stimulation of Adipocyte Differentiation Requires the Synergistic Action of Epac- and cAMP-Dependent Protein Kinase-Dependent Processes , 2008, Molecular and Cellular Biology.

[4]  S. Chiou,et al.  cAMP/PKA Regulates Osteogenesis, Adipogenesis and Ratio of RANKL/OPG mRNA Expression in Mesenchymal Stem Cells by Suppressing Leptin , 2008, PloS one.

[5]  E. Thompson,et al.  Zymosan-induced inflammation stimulates neo-adipogenesis , 2008, International Journal of Obesity.

[6]  E. Thompson,et al.  Monocyte Chemoattractant Protein‐1 and Nitric Oxide Promote Adipogenesis in a Model That Mimics Obesity , 2007, Obesity.

[7]  D. Klemm,et al.  Depletion of cAMP-response Element-binding Protein/ATF1 Inhibits Adipogenic Conversion of 3T3-L1 Cells Ectopically Expressing CCAAT/Enhancer-binding Protein (C/EBP) α, C/EBP β, or PPARγ2* , 2006, Journal of Biological Chemistry.

[8]  Wenjiang J. Fu,et al.  Regulatory role for the arginine-nitric oxide pathway in metabolism of energy substrates. , 2006, The Journal of nutritional biochemistry.

[9]  Norbert Pallua,et al.  Implantation of preadipocyte-loaded hyaluronic acid-based scaffolds into nude mice to evaluate potential for soft tissue engineering. , 2005, Biomaterials.

[10]  K. Wellen,et al.  Inflammation, stress, and diabetes. , 2005, The Journal of clinical investigation.

[11]  C. Polytarchou,et al.  Soluble guanylyl cyclase activation promotes angiogenesis , 2005, Journal of Pharmacology and Experimental Therapeutics.

[12]  Lakeshia J Taite,et al.  Nitric oxide-producing polyurethanes. , 2005, Biomacromolecules.

[13]  Arya M. Sharma,et al.  Regulation of the nitric oxide system in human adipose tissue Published, JLR Papers in Press, July 1, 2004. DOI 10.1194/jlr.M300322-JLR200 , 2004, Journal of Lipid Research.

[14]  J. Cooke.  NO and angiogenesis. , 2003, Atherosclerosis. Supplements.

[15]  G. Shillabeer,et al.  Nitric oxide promotes differentiation of rat white preadipocytes in culture Published, JLR Papers in Press, September 16, 2002. DOI 10.1194/jlr.M200305-JLR200 , 2002, Journal of Lipid Research.

[16]  C. Klein.  Nitric oxide and the other cyclic nucleotide. , 2002, Cellular signalling.

[17]  C. Patrick,et al.  Long-term implantation of preadipocyte-seeded PLGA scaffolds. , 2002, Tissue engineering.

[18]  C. Bogdan,et al.  NO as a signaling molecule: effects on kinases. , 2001, International immunopharmacology.

[19]  S. K. Kim,et al.  Increases in nitric oxide concentrations correlate strongly with body fat in obese humans. , 2001, Clinical chemistry.

[20]  C. George,et al.  Reaction of nitric oxide at the beta-carbon of enamines. A new method of preparing compounds containing the diazeniumdiolate functional group. , 2000, The Journal of organic chemistry.

[21]  P. Arner,et al.  Expression of nitric oxide synthases in subcutaneous adipose tissue of nonobese and obese humans. , 2000, Journal of lipid research.

[22]  D. Feinstein,et al.  Regulation of the expression of the inflammatory nitric oxide synthase (NOS2) by cyclic AMP , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[23]  E. Lakatta,et al.  Activation of distinct cAMP-dependent and cGMP-dependent pathways by nitric oxide in cardiac myocytes. , 1999, Circulation research.

[24]  P. Arner,et al.  A nitric oxide‐mediated mechanism regulates lipolysis in human adipose tissue in vivo , 1999, British journal of pharmacology.

[25]  I. Shoshani,et al.  Adenylyl cyclase P-site ligands accelerate differentiation in Ob1771 preadipocytes. , 1999, American Journal of Physiology.

[26]  E. Clementi,et al.  Effects of nitric oxide on proliferation and differentiation of rat brown adipocytes in primary cultures , 1998, British journal of pharmacology.

[27]  R. Michler,et al.  Apoptosis and increased expression of inducible nitric oxide synthase in human allograft rejection. , 1998, Transplantation.

[28]  D. Bredt,et al.  Perspectives Series : Nitric Oxide and Nitric Oxide Synthases Nitric Oxide in Excitable Tissues : Physiological Roles and Disease , 2013 .

[29]  E. Clementi,et al.  Nitric oxide effects on cell growth: GMP‐dependent stimulation of the AP‐1 transcription complex and cyclic GMP‐independent slowing of cell cycling , 1997, British journal of pharmacology.

[30]  T. Yoshimoto,et al.  Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-α in brown adipocytes , 1997 .

[31]  J. Himms-Hagen,et al.  Obesity and diabetes and the beta-3 adrenergic receptor. , 1997, European journal of endocrinology.

[32]  J. Ntambi,et al.  cAMP Activates the Expression of Stearoyl-CoA Desaturase Gene 1 during Early Preadipocyte Differentiation* , 1996, The Journal of Biological Chemistry.

[33]  R. Idzerda,et al.  Genetically lean mice result from targeted disruption of the RIIβ subunit of protein kinase A , 1996, Nature.

[34]  S. Moncada,et al.  Nitric oxide: physiology, pathophysiology, and pharmacology. , 1991, Pharmacological reviews.

[35]  B. Spiegelman,et al.  Fibronectin modulation of cell shape and lipogenic gene expression in 3t3-adipocytes , 1983, Cell.

[36]  J. Pairault,et al.  A study of the adipose conversion of suspended 3T3 cells by using glycerophosphate dehydrogenase as differentiation marker. , 1979, Proceedings of the National Academy of Sciences of the United States of America.

[37]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[38]  B. Rossatti.  Revascularisation and phagocytosis in free fat autografts: an experimental study. , 1961, British journal of plastic surgery.

[39]  E. Montanya,et al.  Interleukin-1beta and inducible form of nitric oxide synthase expression in early syngeneic islet transplantation. , 2007, The Journal of endocrinology.

[40]  D. Klemm,et al.  Depletion of cAMP-response element-binding protein/ATF1 inhibits adipogenic conversion of 3T3-L1 cells ectopically expressing CCAAT/enhancer-binding protein (C/EBP) alpha, C/EBP beta, or PPAR gamma 2. , 2006, The Journal of biological chemistry.

[41]  T. Yoshimoto,et al.  Nitric oxide mediates down regulation of lipoprotein lipase activity induced by tumor necrosis factor-alpha in brown adipocytes. , 1997, European journal of pharmacology.

[42]  R. Surwit,et al.  Strain-Specific Response toβ 3-Adrenergic Receptor Agonist Treatment of Diet-Induced Obesity in Mice1. , 1997, Endocrinology.